PSMA–DA1
PSMA–DA1 may be a useful PSMA-targeting radiotheranostic agent.
Product Specifications
CAS Number
2703051-77-6
UNSPSC
12352005
Target
PSMA
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/psma-da1.html
Purity
98.85
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](C(O)=O)CCCCNC(CCCC1=CC=C(I)C=C1)=O)CCC(C(O)=O)N2CCN(CC(O)=O)CCN(CCN(CC(O)=O)CC2)C(C(O)=O)CCC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O
Molecular Formula
C50H76IN9O20
Molecular Weight
1250.09
References & Citations
[1]Iikuni S, et al. Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. J Med Chem. 2021 Sep 23;64 (18) :13429-13438.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-15481R-BF405 100 µL
HHR23A Polyclonal Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details RC206281L4 10 µg
EAAT3 (SLC1A1) (NM_004170) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details 